PCN Insights, News, Videos, and More
Videos
10/20/2020
In this video, Joseph F. Goldberg, MD, explains the conditions under which lithium may be an effective treatment for patients with bipolar disorder.
In this video, Joseph F. Goldberg, MD, explains the conditions under which lithium may be an effective treatment for patients with bipolar disorder.
In this video, Joseph F....
10/20/2020
Psych Congress Network
Videos
10/20/2020
In this video, Sanjai Rao, MD, of the University of California San Diego School of Medicine, discusses whether genomic data can aid in the diagnosis of schizophrenia.
In this video, Sanjai Rao, MD, of the University of California San Diego School of Medicine, discusses whether genomic data can aid in the diagnosis of schizophrenia.
In this video, Sanjai Rao, MD,...
10/20/2020
Psych Congress Network
News
10/20/2020
Legislation that will establish “988” as the universal telephone number to reach the United States’ suicide prevention and mental health crisis hotline system has been signed into law.
Legislation that will establish “988” as the universal telephone number to reach the United States’ suicide prevention and mental health crisis hotline system has been signed into law.
Legislation that will establish...
10/20/2020
Psych Congress Network
News
10/19/2020
The prevalence of suicide-related behaviors among physicians is “relatively high,” according to a systematic review and meta-analysis published online in the journal Suicide and Life-Threatening Behavior.
The prevalence of suicide-related behaviors among physicians is “relatively high,” according to a systematic review and meta-analysis published online in the journal Suicide and Life-Threatening Behavior.
The prevalence of...
10/19/2020
Psych Congress Network
News
10/19/2020
A higher level of cardiorespiratory fitness is associated with a lower risk of incident depressive symptoms, according to a study published online in the Journal of Affective Disorders.
A higher level of cardiorespiratory fitness is associated with a lower risk of incident depressive symptoms, according to a study published online in the Journal of Affective Disorders.
A higher level of...
10/19/2020
Psych Congress Network
Videos
10/19/2020
Neurodevelopmental pediatrician Frank Lopez, MD, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).
Neurodevelopmental pediatrician Frank Lopez, MD, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).
Neurodevelopmental pediatrician...
10/19/2020
Psych Congress Network
News
10/15/2020
MindMed, the psychedelic biotech firm, recently announced a commitment to provide $5 million over five years for a psychedelic medicine research training program in collaboration with NYU Langone Health and NYU Grossman School of Medicine....
MindMed, the psychedelic biotech firm, recently announced a commitment to provide $5 million over five years for a psychedelic medicine research training program in collaboration with NYU Langone Health and NYU Grossman School of Medicine....
MindMed, the psychedelic biotech...
10/15/2020
Psych Congress Network
News
10/15/2020
Zuranolone, an investigational neuroactive steroid, improved depressive symptoms in a majority of patients within a 14-day treatment course, topline results from an ongoing phase 3 open-label study show.
Zuranolone, an investigational neuroactive steroid, improved depressive symptoms in a majority of patients within a 14-day treatment course, topline results from an ongoing phase 3 open-label study show.
Zuranolone, an investigational...
10/15/2020
Psych Congress Network
Videos
10/13/2020
In this video, neuropsychiatrist Theresa Cerulli, MD, addresses the myth that most cases of attention-deficit/hyperactivity disorder (ADHD) are simple to treat.
In this video, neuropsychiatrist Theresa Cerulli, MD, addresses the myth that most cases of attention-deficit/hyperactivity disorder (ADHD) are simple to treat.
In this video, neuropsychiatrist...
10/13/2020
Psych Congress Network
News
10/13/2020
Two advisory committees appointed by the US Food and Drug Administration (FDA) have voted in favor of ALKS 3831, a combination of olanzapine and the novel molecular entity samidorphan, Alkermes announced.
Two advisory committees appointed by the US Food and Drug Administration (FDA) have voted in favor of ALKS 3831, a combination of olanzapine and the novel molecular entity samidorphan, Alkermes announced.
Two advisory committees...
10/13/2020
Psych Congress Network
